A detailed history of Aigen Investment Management, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Aigen Investment Management, LP holds 5,959 shares of HAE stock, worth $437,092. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,959
Holding current value
$437,092
% of portfolio
0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$72.45 - $91.58 $431,729 - $545,725
5,959 New
5,959 $478,000
Q1 2022

May 05, 2022

SELL
$43.77 - $63.22 $332,652 - $480,472
-7,600 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $376,580 - $566,884
7,600 New
7,600 $397,000
Q2 2020

Aug 10, 2020

SELL
$84.96 - $118.91 $47,407 - $66,351
-558 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$74.34 - $121.82 $2.28 Million - $3.74 Million
-30,699 Reduced 98.21%
558 $56,000
Q4 2019

Feb 04, 2020

BUY
$114.37 - $129.46 $3.57 Million - $4.05 Million
31,257 New
31,257 $3.59 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.76B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.